Catalog |
name |
Description |
price |
R-M1-8167 |
mPEG5K-FHKHKSPALSPV |
mPEG5K-FHKHKSPALSPV is a synthetic peptide compound. |
price> |
R-M1-8356 |
pHLIP-SS-DOX |
PHLIP SS DOX (pH low insertion peptide SS DOX) is a pH and reducing reactive peptide drug conjugate (PDC) with the ability to target acidic tumor cells and reverse MDR. PH low insertion peptide (pHLIP) is a cell penetrating protein (CPP) with pH dependent transmembrane ability. |
price> |
R-M1-8481 |
Chitosan50k-FFVLGGGFKRIVQRIKDFLR |
Chitosan-FFVLGGGFKRIVQRIKDFLR is a specific peptide sequence that is conjugated with chitosan, a biopolymer derived from chitin.
Chitosan-FFVLGGGFKRIVQRIKDFLR is often used as a functionalized biomaterial or as a drug delivery system in various biomedical applications. By conjugating a bioactive peptide sequence with chitosan, it combines the regenerative and antimicrobial properties of chitosan with the specific cell-binding and signaling abilities of the peptide. |
price> |
R-M1-8497 |
RGD-alginate |
RGD-alginate/RGD-peptide modified alginate/arginine-glycine-aspartate (RGD)-peptide-coupled alginates is a biomaterial consisting of alginate, a polysaccharide derived from seaweed, that has been modified with the RGD peptide sequence. RGD-alginate is commonly used in biomedical applications, particularly in tissue engineering and regenerative medicine.The RGD peptide sequence (Arg-Gly-Asp) is known for its ability to specifically bind to integrin receptors on cell surfaces. Integrins are cell surface proteins that play a critical role in cell adhesion, migration, and signaling. Integrin binding to the RGD sequence promotes cell attachment and interaction with the biomaterial. |
price> |
R-M1-8553 |
Fmoc-TK-COOH |
Fmoc-TK-COOH can be used as a building block in peptide synthesis for the preparation of longer peptides or as a starting point for the conjugation of other molecules. The Fmoc group can be selectively removed to reveal the N-terminal amino group for subsequent reactions or peptide elongation. The threonine and lysine residues in the peptide sequence can contribute to the functionality or properties of the resulting peptide. |
price> |
R-M1-8569 |
Cholesterol-Arg |
Cholesterol-Arg can be done to modify the properties of cholesterol for specific applications. This modification can alter its solubility, cellular uptake, or targeting abilities. The resulting cholesterol-arginine conjugate can be used in various research or biomedical applications, such as drug delivery systems, lipid-based nanoparticles, or cell-penetrating peptides. |
price> |
R-M1-8572 |
C18-ELP3(VPGVGVPGVGVPGVG) |
The sequence "C18-ELP3(VPGVGVPGVGVPGVG)" suggests a modified or tagged version of the ELP3 protein. The "C18" indicates that there is a cysteine residue at position 18 that has been modified or added to the protein. "ELP3" refers to the ELP3 gene, which likely encodes for the protein. "(VPGVGVPGVGVPGVG)" represents a sequence motif or modification within the protein, possibly indicating a repeated motif of valine (V), proline (P), and glycine (G). |
price> |
R-M1-8668 |
N3-Angiopep-2 |
N3-Angiopep-2/N3 modified Angiopep-2 (TFFYGGSRGKRNNFKTEEYC)/N3-TFFYGGSRGKRNNFKTEEYC/Azide-TFFYGGSRGKRNNFKTEEYC/Azide modified Angiopep-2 (TFFYGGSRGKRNNFKTEEYC) refers to a modified version of the peptide Angiopep-2. Angiopep-2 is a peptide that has been identified as a ligand with the ability to target the low-density lipoprotein receptor-related protein 1 (LRP1) at the blood-brain barrier (BBB). The N3 modification is a chemical modification made to enhance the stability and uptake of the peptide.The N3-Angiopep-2 peptide has been utilized in drug delivery systems to target and facilitate the transport of therapeutic agents across the blood-brain barrier. This modification enables better penetration of the peptide across the BBB and improves the delivery of drugs to the central nervous system for the treatment of various neurological disorders. |
price> |
R-M1-8687 |
SH-IFLLWQR |
Thiol modified IFLLWQR/Thiol modified Ile-Phe-Leu–Leu-Trp-Gln-Arg/Thiol-IFLLWQR(Ile-Phe-Leu–Leu-Trp-Gln-Arg,IF7)/SH-IFLLWQR(Ile-Phe-Leu–Leu-Trp-Gln-Arg,IF7) can be used for research on targeting tumor cells. |
price> |
R-M1-8760 |
NapGFFY-E(Deferroamine)ALKRQGRTLYGFGG-CONH2 |
NapGFFY-E(Deferroamine)ALKRQGRTLYGFGG-CONH2 is a modified peptide with a specific combination of amino acids and ferroamine modifications. |
price> |